Bars

BioCentury This Week

266 - Ep. 257 - Schizophrenia, Sickle Cell Drugs, D.C. Update
BioCentury This Week
266 - Ep. 257 - Schizophrenia, Sickle Cell Drugs, D.C. Update
Unfavorite

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.

For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Playlist

More episodes

  • BioCentury This Week
    266 - Ep. 257 - Schizophrenia, Sickle Cell Drugs, D.C. Update
    Mon, 30 Sep 2024
    Play
  • BioCentury This Week
    265 - Ep. 256 - ESMO Recap: Keeping TIGIT Alive, Rybrevant & Immunotherapy Anniversary
    Wed, 25 Sep 2024
    Play
  • BioCentury This Week
    264 - Ep. 255 - Pediatric PRVs, Biosecure & Novo's Obesity Miss
    Mon, 23 Sep 2024
    Play
  • BioCentury This Week
    263 - Ep. 254 - Takeaways from Grand Rounds 2024
    Fri, 20 Sep 2024
    Play
  • BioCentury This Week
    262 - Ep. 253 - IPOs, GLP-1 & Obesity, AI & Biotech
    Mon, 16 Sep 2024
    Play
Daha fazla bölüm göster
Microphone

Daha fazla bilim & tıp pod yayını

Microphone

Daha fazla bilim & tıp uluslararası pod yayını